Annual Current Liabilities
$39.23 M
+$22.93 M+140.70%
31 December 2023
Summary:
Assembly Biosciences annual total current liabilities is currently $39.23 million, with the most recent change of +$22.93 million (+140.70%) on 31 December 2023. During the last 3 years, it has risen by +$14.79 million (+60.54%). ASMB annual current liabilities is now at all-time high.ASMB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$41.63 M
+$361.00 K+0.87%
30 September 2024
Summary:
Assembly Biosciences quarterly total current liabilities is currently $41.63 million, with the most recent change of +$361.00 thousand (+0.87%) on 30 September 2024. Over the past year, it has increased by +$34.50 million (+483.78%). ASMB quarterly current liabilities is now at all-time high.ASMB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +140.7% | +483.8% |
| 3 y3 years | +60.5% | +178.9% |
| 5 y5 years | +112.3% | +93.7% |
ASMB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +144.0% | at high | +483.8% |
| 5 y | 5 years | at high | +144.0% | at high | +483.8% |
| alltime | all time | at high | +3621.5% | at high | >+9999.0% |
Assembly Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $41.63 M(+0.9%) |
| June 2024 | - | $41.27 M(+6.5%) |
| Mar 2024 | - | $38.75 M(-1.2%) |
| Dec 2023 | $39.23 M(+140.7%) | $39.23 M(+450.0%) |
| Sept 2023 | - | $7.13 M(-19.2%) |
| June 2023 | - | $8.83 M(-11.4%) |
| Mar 2023 | - | $9.97 M(-38.8%) |
| Dec 2022 | $16.30 M(+1.4%) | $16.30 M(+5.4%) |
| Sept 2022 | - | $15.46 M(+3.3%) |
| June 2022 | - | $14.96 M(+39.7%) |
| Mar 2022 | - | $10.71 M(-33.4%) |
| Dec 2021 | $16.07 M(-34.2%) | $16.07 M(+7.7%) |
| Sept 2021 | - | $14.93 M(+7.3%) |
| June 2021 | - | $13.91 M(-4.0%) |
| Mar 2021 | - | $14.50 M(-40.7%) |
| Dec 2020 | $24.43 M(-0.0%) | $24.43 M(+45.4%) |
| Sept 2020 | - | $16.80 M(-2.7%) |
| June 2020 | - | $17.27 M(-18.3%) |
| Mar 2020 | - | $21.15 M(-13.5%) |
| Dec 2019 | $24.44 M(+32.3%) | $24.44 M(+13.7%) |
| Sept 2019 | - | $21.50 M(+7.8%) |
| June 2019 | - | $19.93 M(-20.9%) |
| Mar 2019 | - | $25.20 M(+36.4%) |
| Dec 2018 | $18.47 M(+36.9%) | $18.47 M(+26.4%) |
| Sept 2018 | - | $14.61 M(+11.3%) |
| June 2018 | - | $13.13 M(+7.8%) |
| Mar 2018 | - | $12.18 M(-9.7%) |
| Dec 2017 | $13.49 M | $13.49 M(+10.4%) |
| Sept 2017 | - | $12.22 M(+1.9%) |
| June 2017 | - | $11.99 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $10.96 M(+53.9%) |
| Dec 2016 | $7.12 M(+109.3%) | $7.12 M(-4.8%) |
| Sept 2016 | - | $7.48 M(+48.3%) |
| June 2016 | - | $5.04 M(+41.3%) |
| Mar 2016 | - | $3.57 M(+4.9%) |
| Dec 2015 | $3.40 M(+222.9%) | $3.40 M(+28.3%) |
| Sept 2015 | - | $2.65 M(+18.4%) |
| June 2015 | - | $2.24 M(+5.2%) |
| Mar 2015 | - | $2.13 M(+101.9%) |
| Dec 2014 | $1.05 M(-60.0%) | $1.05 M(+0.5%) |
| Sept 2014 | - | $1.05 M(-28.6%) |
| June 2014 | - | $1.47 M(+0.5%) |
| Mar 2014 | - | $1.46 M(-44.6%) |
| Dec 2013 | $2.64 M(-3.9%) | $2.64 M(+13.8%) |
| Sept 2013 | - | $2.32 M(-10.4%) |
| June 2013 | - | $2.59 M(+30.8%) |
| Mar 2013 | - | $1.98 M(-28.0%) |
| Dec 2012 | $2.75 M(+9.2%) | $2.75 M(+2.4%) |
| Sept 2012 | - | $2.68 M(-21.0%) |
| June 2012 | - | $3.39 M(-12.0%) |
| Mar 2012 | - | $3.85 M(+53.3%) |
| Dec 2011 | $2.51 M(+46.1%) | $2.51 M(+112.4%) |
| Sept 2011 | - | $1.18 M(+53.7%) |
| June 2011 | - | $769.90 K(+148.0%) |
| Mar 2011 | - | $310.40 K(-82.0%) |
| Dec 2010 | $1.72 M(-86.1%) | $1.72 M(-89.4%) |
| Sept 2010 | - | $16.29 M(+8.6%) |
| June 2010 | - | $15.00 M(+9.3%) |
| Mar 2010 | - | $13.73 M(+11.1%) |
| Dec 2009 | $12.36 M(+162.2%) | $12.36 M |
| Dec 2008 | $4.71 M | - |
FAQ
- What is Assembly Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Assembly Biosciences?
- What is Assembly Biosciences annual current liabilities year-on-year change?
- What is Assembly Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Assembly Biosciences?
- What is Assembly Biosciences quarterly current liabilities year-on-year change?
What is Assembly Biosciences annual total current liabilities?
The current annual current liabilities of ASMB is $39.23 M
What is the all time high annual current liabilities for Assembly Biosciences?
Assembly Biosciences all-time high annual total current liabilities is $39.23 M
What is Assembly Biosciences annual current liabilities year-on-year change?
Over the past year, ASMB annual total current liabilities has changed by +$22.93 M (+140.70%)
What is Assembly Biosciences quarterly total current liabilities?
The current quarterly current liabilities of ASMB is $41.63 M
What is the all time high quarterly current liabilities for Assembly Biosciences?
Assembly Biosciences all-time high quarterly total current liabilities is $41.63 M
What is Assembly Biosciences quarterly current liabilities year-on-year change?
Over the past year, ASMB quarterly total current liabilities has changed by +$34.50 M (+483.78%)